Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Capital/Financing Update 2020

Apr 8, 2020

65044_rns_2020-04-08_739ffef8-00da-4248-af25-542356173627.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [215 x 49] intentionally omitted <==

Holista CollTech Limited

(ASX:HCT / ABN 24 094 515 992) 283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500; F: +61 8 6141 3599 W: www.holistaco.com

ASX Announcement

9 April 2020

HOLISTA’S U.S. DISTRIBUTOR INCREASES ORDERS OF NATSHIELD™ AMOUNTING TO A$3.8M

KUALA LUMPUR/PERTH, 9 April 2020 – Holista CollTech (ASX:HCT, “Holista”) refers to its announcement of 19 March 2020 regarding the appointment of Health Therapies LLC (“Health Therapies”) as its exclusive distributor for the United States for the Company’s NatShield™ a handheld sanitiser which contains the Path-Away® active ingredient. Path-Away® is developed by Global Infections Control Consultants LLC (“GICC LLC”), headquartered in Bluffton, South Carolina in the United States, which has been proven as an effective broad-spectrum sanitiser.

Following the first and second shipment from Malaysia totalling 9,558 30-ml bottles of NatShield™ to date, Health Therapies has placed additional orders for 415,000 bottles totalling A$3.8 million for delivery between April and June 2020.

Of the latter order 15,000 bottles of 30-ml will be shipped in April, while 400,000 60-ml bottles are expected to be delivered through May and June.

The company is also pleased to report that it has managed to secure bottles and bottling companies to support this order by working with an interdependent supply chain networks which span South Carolina, Georgia and Florida. This is important given that supply chains for sanitsers have been constrained due to the ongoing pandemic and much of North America is in some form of lockdown.

The accelerated orders follow strong demand received by Health Therapies from stores as well as U.S. State Administrations in and around New York, where infection and fatalities due to the COVID-19 novel coronavirus has increased significantly in recent days.

Holista expects to record revenue of A$3.8 million from combined total orders of 424,558 bottles of NatShield™ received in the United Sates of America to date from Health Therapies.

Holista has the global distribution rights of the plant-based Path-Away®, sold as a sanitiser under the trademark of NatShield™. Health Therapies is headquartered in New Jersey and has a marketing team with 40 years of experience across various sales channels.

This announcement has been approved for release by all members of the Holista Board.

Authorised by:

Dr Rajen Manicka Managing Director

#END#

About Holista CollTech Ltd

Holista CollTech Ltd (“Holista”) is a natural wellness company, the result of a merger between Holista Biotech Sdn Bhd and CollTech Australia Ltd. The company has 3 main divisions:

  • Dietary supplements and personal care

  • Food Ingredients

  • Ovine collagen

Holista has a global collaboration with Path-Away®, a plant-based solution that is proven to kill a board spectrum of microbes. The all natural alcohol-free solution is an active ingredient in Holista’s proprietary hand sanitiser, NatShield™ that is sold under its personal care space.

Listed on the Australian Securities Exchange (“ASX”), Holista researches, develops, manufactures and markets “health-style” products to address the unmet and evolving needs of natural medicine. Holista’s suite of ingredients includes low-GI baked products, reduced-sodium salts, low-fat fried foods and low-calorie sugar without compromising taste, odour and mouthfeel. Holista remains the only company to produce sheep (ovine) collagen using patented extraction methods. For more information, please refer to http://www.holistaco.com

For further information, please contact:

Corporate Affairs & Business Opportunities

Dr Rajen Manicka: [email protected] General Enquiries: [email protected]

Australia

283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500 ; F: +61 8 6141 3599

Malaysia

12th Floor, Amcorp Trade Centre, PJ Tower No. 18, Persiaran Barat off Jalan Timur 46000, Petaling Jaya, Malaysia

P: +603 7965 2828 ; F: +603 7965 2777

Media and Investor Relations Enquiries WeR1 Consultants Pte Ltd 3 Phillip Street #12-01 Singapore 048693 E: [email protected]; P: +65 67374844